Tag Archives: market access

Recent Activities Position AscellaHealth As a Leader in Specialty Pharmaceutical Services

AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services

OWP Pharmaceuticals and EVERSANA Announce Commercialization Partnership

OWP Pharmaceuticals and EVERSANA Announce Partnership to Commercialize Oral Liquid Formulations to Treat Neuroscience Disorders

Veradigm and CareMetx Partner to Optimize Specialty Medication Access

Many hub service providers and other companies develop patient support platforms to offer patient-centric capabilities in order to provide better services that improve patient outcomes

Phil, Inc. Disrupting Traditional Hub Services Provider Market

A number of innovative companies have entered the increasingly competitive traditional specialty pharmaceutical Hub services market

Indegene Acquires Medical Marketing Economics (MME)

Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities

EVERSANA Partners With Resverlogix to Commercialize Breakthrough Cardiovascular/CKD drug

In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services

Genentech (Roche) and Blueprint Medicines Collaborate to Increase Market Access

Both Gavreto and AYVAKIT are available through Blueprint’s specialty distribution network and two specialty pharmacies: Biologics by McKesson and PantherRx

Tanner Pharma Group Increasing Product Access With Named Patient Programs

A Named Patient Program (NPP) provides patients and physicians access to commercially approved medicines that are not available to them in their own country